Learn

Webinars

Advancing PKD Care in Today's Society: April 22nd 2021
This webinar included an overview of a series of resources that Dr. Micheli (Mike) Bevilacqua and his team at BC Renal have developed in British Columbia for ADPKD care. These resources are to help with delivering more tailored services to ADPKD patients in kidney clinics.  The goal is to put tools in place so that all kidney clinics can offer ADPKD specific care, supported by a network of clinicians around the province. Dr. Micheli (Mike) Bevilacqua will explain how their plan was developed, how it will be implemented, and what they have learned so far. Although this webinar relates to patient care in British Columbia, the information and resources shared are of value to patients nation-wide.



La maladie polykystique des reins et le vaccin Pfizer-BioNTech contre la COVID-19: 17 février 2021
La COVID-19 représente un sérieux danger pour la santé, et son effet sur nos vies ne cesse d’évoluer chaque jour. En cette période sans précédent, les personnes présentant des affections préexistantes doivent être d’autant plus vigilantes. Alors que le vaccin Pfizer-19 est en cours de distribution au Canada, de nombreuses personnes souffrant de MPR se posent des questions. Nous avons pour objectif de vous fournir les informations les plus récentes relatives à ce virus et au vaccin, pour vous aider à avoir l’esprit tranquille en ces temps difficiles.


Polycystic Kidney Disease & the Pfizer-BioNTech COVID-19 Vaccine, with Dr. York Pei: January 21st 2021
COVID-19 is a serious health concern and the impact on our lives continues to evolve on a daily basis. In these unprecedented times, individuals with pre-existing conditions need to be especially careful. With the distribution of the Pfizer-BioNTech COVID-19 Vaccine under way in Canada, many of those affected by PKD have questions.  It is our goal to provide you with up-to-date information as it relates to this virus, the vaccine, and to help ease your mind during this challenging time.




Case Study Presentation with Dr. Sebastian Strubl: Experience of People with ADPKD with Ketogenic Diets-Feasibility & Effects: October 29th 2020
Recently, the Weimbs laboratory (UC Santa Barbara) has published the first evidence that induction of ketosis via ketogenic diet or intermittent fasting ameliorates disease progression in animal models of PKD. Due to their common use for weight control or for other health benefits, ADPKD patients may already have experimented with ketogenic dietary interventions. This case series study was designed to gain first insights about possible effects and the feasibility of ketogenic diets for ADPKD patients.




Managing Depression and Anxiety with Polycystic Kidney Disease with Carla Willaims, BSW, RSW: August 27th 2020
The PKD Foundation of Canada was proud to present this complimentary webinar that gave the PKD community the opportunity to ask questions to Carla Williams, a Kidney Care Clinic and Transplant Social Worker.





How COVID-19 Affects the PKD Population with Dr. Matthew Lanktree: July 4th 2020
COVID-19 is a serious health concern and the impact on our lives continues to evolve on a daily basis. In these unprecedented times, individuals with pre-existing conditions need to be especially careful. It is our goal to provide you with up-to-date information as it relates to this virus, and to help ease your mind during this challenging time.




How COVID-19 Affects the PKD Population Q&A with Dr. Matthew Lanktree: July 4th 2020
The PKD Foundation of Canada is proud to present the recording of our webinar, How COVID-19 Affects the PKD Community. This portion of our webinar gave our community the opportunity to ask questions to one of Canada’s leading ADPKD specialists, Dr. Matthew Lanktree.